$TLRY news
The latest TLRY stock news: headlines, filings, AI summaries and sentiment for $TLRY, updated around the clock.
- Tilray Brands Shares Decline 7%, Extending Month-Long Selloff
- Tilray Raises Fiscal 2027 Adjusted EBITDA Guidance Following Canadian Operational Consolidation
- Tilray Reports Record $257 Million Quarterly Revenue Amid Declining Cannabis Sales
- Comparative Revenue Analysis of Canopy Growth and Tilray Brands
- Tilray Reports Q1 2027 Earnings: Revenue Growth Driven by BrewDog Acquisition
- Major Earnings Announcements Before Market Open on Thursday
- Tilray Reaffirms FY2027 Adjusted EBITDA Guidance Amid Integration of BrewDog and Preparations for Carlsberg Deal
- Tilray Reports Lower Than Expected Revenue in Q1
- Tilray Reports Surge in Beverage Alcohol Sales and Decline in Cannabis Revenue
- Tilray Exceeds Q1 Earnings Expectations and Reaffirms Fiscal Year 2027 Outlook
- Tilray Reports Mixed Q1 Results; Reaffirms FY27 Outlook
- Tilray Brands, Inc. - 8-K Filing
- Tilray Q1 Earnings Preview: Revenue Expected to Rise
- Tilray Stock Continues to Decline Despite Record Revenue
- Tilly's Turns Profitable After Closing 40 Stores
- Trump Administration Advances Federal Marijuana Rescheduling; Tilray Stock in Focus
- Tilray Brands, Inc. - 8-K Filing
- Tilray's Stock Struggles Despite Regulatory Progress
- Tilray's Distribution Segment Drives Most Growth in Fiscal 2026
- Tilray's Distribution Segment Drives Most of Its Growth in Fiscal 2026
- Jefferies Reiterates 'Buy' Rating on Tilray Brands Despite Lower Earnings Forecasts
- Tilray Brands Shares Rise Over 8%
- Tilray Brands Reports Record Fiscal 2026 Performance with Revenue and EBITDA Growth
- Tilray Projects $68M-$75M Adjusted EBITDA in Fiscal 2027 as It Targets Margin Expansion
- Tilray Brands, Inc. - 8-K Filing
- Major Companies to Report Earnings After Market Close on Tuesday
- Tilray Earnings Preview: Q4 Results Expected on Tuesday
- Tilray Launches Discreet THC Pouch Product Zonna
- UK Data Watchdog Investigates Complaints Over James Watt’s BrewDog Buyback Bid
- President Trump Reschedules Marijuana to Schedule III: Impact on Canopy Growth, Green Thumb, and Tilray
- Trump Executive Order Reschedules Medical Marijuana; Impact on Cannabis Companies
- James Watt Attempts Second Bid to Buy Back UK Assets of BrewDog
- James Watt Bids to Buy Back BrewDog from Tilray Brands
- Tilray Stock Falls Nearly 19% Amid Share Issuance and Analyst Downgrade
- Tilray Acquires Digital Health Platform HelloMD
- Aurora Cannabis Reports Strong FY26 Performance with Medical Sales Growth
- Tilray's Acquisition of Brewdog Faces Challenges as UK Sales Decline
- Canopy Growth Announces Restatement of Two Years' Financials Ahead of June Earnings
- Canopy Growth Announces Restatement of Two Years' Financial Results Ahead of Earnings
- Tilray's Marijuana Rescheduling News Fails to Sustain Market Gains
- Tilray Brands' Potential Expansion Into the U.S. Marijuana Market Remains Uncertain
- Tilray's Stock Reaction to U.S. Marijuana Rescheduling Policy
- Marijuana Reclassified from Schedule I to Schedule III, Impact on Cannabis Stocks
- Tilray Brands Shares Rise on Rescheduling Speculation
- Tilray Brands Struggles Despite Legal Cannabis Market in Canada